Abstract:Colon holds a complex microbial community, which is crucial for maintaining homeostasis and regulating metabolic functions, supporting the intestinal barrier and controlling immune responses. Previous studies have supported a link between intestinal microbiota and colorectal cancer (CRC). Based on these fndings, the present review analyzed the numerous interactions that occur between microbiota and CRC, starting from the role of intestinal microbiota in colonic homoeostasis. Intestinal microbiota is a cause of CRC and involves various mechanisms such as chronic inﬂammation, the production of genotoxins causing DNA impairment and/or the biosynthesis of toxic compounds. Moreover, basic metabolic factors such as short-chain fatty acids (SCFAs) and bile acids are included in CRC pathogenesis. Diﬀerent pathogenic pathways have been reported among diﬀerent CRC regions (proximal or distal). Variations in the microbial populations are reported between the CRC from these colonic sites, possibly reﬂecting the bacterial dysbiosis and bioflm distribution. Bowel preparation is essential prior to colonoscopy and surgery; there is, however, minor consensus on the eﬀects of this procedure on intestinal microbiota, notably with regard to the long-term outcomes. With regard to the therapeutic strategy in CRC, the intestinal microbiota is further involved in the modulation of the host response to chemotherapeutic agents (5-ﬂuorouracil and irinotecan) by the interference with drug efcacy and by adverse eﬀects and associated toxicity. In addition, the newly emerged research on CRC immunotherapy reveals an important interplay between intestinal microbiota and the immune system, which includes the possibility of targeting microbiota for the enhancement of anticancer treatment. Additional studies will further clarify the interaction between microbiota and CRC, resulting in the development of alternative therapeutic strategies by manipulating microbiota composition.

The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges

Secondary Bile Acids and Tumorigenesis in Colorectal Cancer

Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis

The Pivotal Role of the Gut Microbiome in Colorectal Cancer

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer

Influence of Bile Acids on Colorectal Cancer Risk: Potential Mechanisms Mediated by Diet-Gut Microbiota Interactions

Effect of gut microbiota in the colorectal cancer and potential target therapy

The Roles of Gut Microbiota Metabolites in the Occurrence and Development of Colorectal Cancer: Multiple Insights for Potential Clinical Applications

Gut microbiome: decision-makers in the microenvironment of colorectal cancer

Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer

The gut microbiome-bile acid axis in hepatocarcinogenesis

Microbial metabolites in colorectal tumorigenesis and cancer therapy

Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis

Gut microbiome in tumorigenesis and therapy of colorectal cancer

Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies

Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend

Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions

Microbe-based management for colorectal cancer

Intestinal microbiota and colorectal cancer: a new aspect of research